Our results suggest that the cost-effectiveness of the integrated program is mainly driven by larvicide applications when the first notification occurs between the beginning of June and the end of August (Fig. 3d).
We suggest that the cost-effectiveness of UK deployment policies needs to be more closely analysed as associated costs are non-trivial and expected to rise.
Additionally, our results suggest that the cost-effectiveness of broad-based policy solutions to improve physical access to large food stores or to stimulate demand may be limited when it comes to easing entry in areas with multiple stores.
Firstly, the authors suggest that the cost-effectiveness of TNF inhibitors may be overestimated.
The authors of these studies suggest that the cost-effectiveness may be more favourable over a longer time horizon.
We therefore suggest that the cost-effectiveness estimates reported by us that have a very wide uncertainty ranges should be considered only indicative at this stage.
These results suggest that the cost-effectiveness of the MRI screening program for BRCA1/2 mutation carriers is finely balanced, with sensitivity to input parameters and statistical uncertainty.
Our analyses suggest that the cost-effectiveness of self-monitoring is robust to variations in these parameters when pooled clinical effect estimates are applied to the model.
While formal analysis would be needed to confirm this, the coefficients on the country parameters in the regression analyses of both costs and outcomes suggest that the cost-effectiveness would be broadly similar in the other countries.
Consequently, we suggest that the cost-effectiveness of high-cost MRSA-specific control measures, such as universal MRSA screening, 13 should be re-examined, given assumptions of declining baseline prevalence.
